[ad_1]
(MedPage Today) — High-dose vitamin D reduced disease activity in clinically isolated syndrome (CIS) and in early relapsing-remitting multiple sclerosis (MS), the D-Lay MS clinical trial showed.
Over 24 months of follow-up, disease activity occurred…
[ad_2]
Source link : https://www.medpagetoday.com/neurology/multiplesclerosis/114587
Author :
Publish date : 2025-03-10 21:31:00
Copyright for syndicated content belongs to the linked Source.